Apatinib Combined with CCI-779 Inhibits the Proliferation and Migration of Small Cell Lung Cancer NCI-H446 Cells In Vitro

Background and objective Lung cancer is the most common malignancy world-wide. Small cell lung cancer is the deadliest subtype of lung cancer, which features such as rapid growth, early metastasis, and high vascularization. Apatinib is a vascular endothelial growth factor receptor 2 inhibitor indepe...

Full description

Bibliographic Details
Main Authors: Chao LIU, Hongbing ZHANG, Yongwen LI, Zihe ZHANG, Ruifeng SHI, Songlin XU, Guangsheng ZHU, Pan WANG, Hongyu LIU, Jun CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.104.08